Ketamine and Addiction Recovery: Understanding the Evidence and Risks

If you are exploring addiction recovery care, it is understandable to ask about emerging treatments. A podcast, testimonial, or clinic advertisement can raise useful questions, but treatment decisions should begin with an assessment of your substance use, health, and available evidence-based options.

Compounded ketamine is not FDA-approved. FDA has not reviewed compounded medications for safety, effectiveness, or quality before marketing. Ketamine injection is approved for anesthesia, not psychiatric disorders. Compounded ketamine nasal spray is different from Spravato, the FDA-approved esketamine product used in certified healthcare settings.

Recovery care should match the substance and the person

The National Institute on Drug Abuse describes behavioral therapies and medications, when appropriate, as parts of addiction treatment. Your clinician should explain which approaches are supported for the substance involved, how withdrawal will be assessed, and what continuing care may involve. A plan may also need to address depression, trauma symptoms, pain, or sleep problems.

What can ketamine research tell us?

Research interest does not establish ketamine as a routine treatment for addiction. Ask whether a cited study involved your diagnosis, the same medication formulation and route, and comparable clinical supervision. Findings from intravenous ketamine or an FDA-approved esketamine product cannot establish the safety or effectiveness of a compounded at-home spray.

Ketamine itself has abuse, misuse, and dependence potential. A history of substance use is important clinical information, not something to leave out of an intake form. Ask how the clinician would assess and respond to cravings, escalating use, or difficulty following the prescription.

Questions to bring to an appointment

• Which established treatments should I consider first or continue?
• Does my withdrawal risk require an urgent or supervised evaluation?
• Which clinician will coordinate addiction treatment and mental health care?
• What outcome would we measure, and when would we reassess the plan?
• What should I do if my substance use or mental health worsens?

Do not stop prescribed addiction treatment or attempt withdrawal on your own because a new treatment sounds promising. Ask your existing care team before making changes. Access through telehealth in Texas or California still requires an individualized assessment of suitability and applicable requirements.

Risks and the treatment setting

Ketamine can cause sedation, dissociation, impaired thinking or coordination, increased blood pressure, and slowed breathing. Other concerns include abuse or misuse, worsening psychiatric symptoms, and urinary or bladder problems. A prescription or lower dose does not eliminate these risks.

At home, a healthcare professional is not onsite to monitor you or respond immediately to an adverse reaction. Virtual follow-up does not provide the same monitoring as an onsite team. Discuss whether the setting is appropriate, your medication interactions, and an emergency plan before treatment.

Discuss your questions with a clinician

Bliss Mist Rx LLC provides telehealth services and does not compound or manufacture medications. If treatment is prescribed, an independent, appropriately licensed compounding pharmacy dispenses the medication. A consultation does not guarantee a prescription; applicable prescribing and compounding requirements must be met.

Book a Free Virtual Appointment or Follow-Up to review your questions, alternatives, and next steps. This article provides general education and does not replace individualized medical advice.

Further reading: NIDA: questions about addiction treatment; FDA: compounded-drug risks.